The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure
Abstract
Milrinone, a derivative of amrinone, has nearly 20 times the inotropic potency of the parent compound and does not cause fever or thrombocytopenia in normal volunteers or in animals sensitive to amrinone. In 20 patients with severe congestive heart failure, intravenous milrinone resulted in significant decreases in left ventricular end-diastolic pressure (from 27 +/- 2 to 18 +/- 2 mm Hg), pulmonary wedge pressure, right atrial pressure, and systemic vascular resistance, as well as a slight reduction in mean arterial pressure. Significant increases occurred in cardiac index (from 1.9 +/- 0.1 to 2.9 +/- 0.2 liters per minute per square meter) and the peak positive first derivative of left ventricular pressure, with a slight increase in heart rate. Hemodynamic improvement was sustained during a 24-hour continuous infusion. Nineteen of the 20 patients subsequently received oral milrinone (29 +/- 2 mg per day) for up to 11 months (mean, 6.0 +/- 0.8), with sustained improvement in symptoms of heart failure. In 10 patients receiving long-term oral milrinone (greater than or equal to 6 months) radionuclide ventriculography showed continued responsiveness, with a 27 per cent increase in left ventricular ejection fraction after 7.5 mg of the drug. Four patients died after a mean of 4.8 months of therapy, and three patients with severe underlying coronary-artery disease and angina pectoris required additional antianginal therapy. No patient had fever, thrombocytopenia, gastrointestinal intolerance, or aggravation of ventricular ectopy. We conclude that milrinone shows promise for the longterm treatment of congestive heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Franciosa, J. A., Wilen, M., Ziesche, S., & Cohn, J. N. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80141-6 · Cited by 672
Digitalis Intoxication: A Prospective Clinical Study with Serum Level Correlations
Beller, G. A., Smith, T. W., Abelmann, W. H., Haber, E., & Hood, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197105062841801 · Cited by 571
Vasodilator Therapy of Cardiac Failure: (First of Two Parts)
Cohn, J. N., & Franciosa, J. A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707072970105 · Cited by 481
Colucci, W. S., Alexander, R. W., Williams, G. H., Rude, R. E., Holman, B. L., Konstam, M. A., Wynne, J., Mudge, G. H., & D, E. B. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107233050402 · Cited by 331
New cardiotonic agents: A search for digitalis substitute
FARAH, A. E., & Alousi, A. A. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90083-8 · Cited by 156
Siskind, S. J., Sonnenblick, E. H., Forman, R. F., Scheuer, J., & LeJemtel, T. H. (1981) · Circulation · doi:10.1161/01.cir.64.5.966 · Cited by 89
A New Inotropic Drug: Its Promise and a Caution
Katz, A. M. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812212992508 · Cited by 81
Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton, I., Murray, R. G., Boyes, R. N., Rae, A. P., & Hillis, W. S. (1980) · Heart · doi:10.1136/hrt.43.2.134 · Cited by 59
New hope for the failing heart
Weber, K. T. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90478-8 · Cited by 22
Cited by
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Packer, M. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90167-l · Cited by 1,056
DiBianco, R., Shabetai, R., Kostuk, W., Moran, J., Schlant, R. C., & Wright, R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201101 · Cited by 550
Feldman, M. D., Copelas, L., Gwathmey, J. K., Phillips, P., Warren, S. E., Schoen, F. J., Grossman, W., & Morgan, J. P. (1987) · Circulation · doi:10.1161/01.cir.75.2.331 · Cited by 486
Self-citationNew Positive Inotropic Agents in the Treatment of Congestive Heart Failure: (Second of Two Parts)
Colucci, W. S., Wright, R. F., & Braunwald, E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602063140605 · Cited by 341
Self-citation
Metadata
- Authors
- Baim, D. S., McDowell, A. V., Cherniles, J., Monrad, E. S., Parker, J. A., Edelson, J., Braunwald, E., & Grossman, W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1983-09-29
- Volume
- 309
- Issue
- 13
- Pages
- 748-756
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2312437912
- Cited by
- 337
- References
- 10
- FWCI
- 27.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure. https://app.cochat.ai/papers/10.1056/nejm198309293091302
- The paper
- Baim, D. S., McDowell, A. V., Cherniles, J., Monrad, E. S., Parker, J. A., Edelson, J., Braunwald, E., & Grossman, W. (1983). Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure. New England Journal of Medicine. https://doi.org/10.1056/nejm198309293091302
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.